Lu-AF-35700

N/A

Report date: 2024/10/10 20:00:04
NME

Base Information

Drug NameLu-AF-35700
Drug Alias NameLu-AF-35700Lu AF356152 prodrug
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor modulators
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaDrug-Related Side Effects and Adverse ReactionsRenal Insufficiency +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[18] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesH. Lundbeck A/SJiangsu Nhwa Pharmaceutical Co LtdLundbeck (Beijing) Pharmaceutical Consulting Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsRenal InsufficiencyHepatic Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A